A leading precision medicine company, ArteraAI develops AI-enabled tests to help personalize therapy for cancer patients.
Joined February 2022
- Tweets 628
- Following 144
- Followers 620
- Likes 113
471 Photos and videos
Dr. Daniel Spratt on Artera’s Post‑RP test:
“[It] uses clinical and pathologic features digital pathology, running AI to help ID patients at low vs high risk of recurrence and metastasis.”
Thanks @UroTimes Hannah Clarke for the feature.
heyor.ca/mI71pa
#ArteraAI
2
4
411
June is #MensHealthMonth.
Hear from our Medical Director, Dr. Ben Fischer-Valuck, on the importance of men's health and how empowered patients make for the best outcomes.
#ProstateCancer #ArteraAI
40
How can AI and genomic classifiers help personalize #prostatecancer radiation therapy?
Dr. Jason Efstathiou discusses the evolving role of biomarkers and AI-driven insights in treatment decision-making.
Watch the interview: buff.ly/5b4e9Ti
#ArteraAI
57
Next stop: @nyulangone.
We'll be attending Advances in Screening, Detection, and Treatment of Prostate Cancer conference this June. Looking forward to important conversations around screening, risk stratification, and evolving #prostatecancer care.
#ArteraOnTheGo
1
39
ICYMI: Dr. Anna Wilkins sat down with UroToday to discuss the validation of Artera's MMAI model in the CHHiP trial. Key findings include how the model can accurately stratify low risk patients from high risk patients.
urotoday.com/video-lectures/…
32
A second opinion changed everything.
On #CancerSurvivorsDay, a reminder that cancer care isn’t just about treating, it’s about making the right decision for each patient.
Read more: buff.ly/UYFk651
#CancerSurvivorship #PrecisionMedicine #NCSD2026
58
That’s a wrap on #ASCO26!
Proud to share Artera data across prostate and breast cancer and continue conversations around multimodal AI and personalized oncology care.
Thanks to everyone who connected with the team in Chicago.
#ArteraOnTheGo
1
88
Artera is expanding its multimodal AI platform into metastatic hormone-sensitive prostate cancer (#mHSPC).
The #ArteraAI Prostate Test (mHSPC) is the first digital pathology-based test designed to help inform treatment planning in mHSPC.
Learn more: buff.ly/AUFtM9j
1
85
What does it take to bring AI into real clinical care?
Great discussion from #ASCOGU on how tools like the #ArteraAI Prostate Test are already shaping decisions today, with potential across cancers.
Watch the interview: buff.ly/q3CHHnb
#PrecisionMedicine
1
45
AI is continuing to reshape #breast cancercare, from screening to personalized treatment insights.
Interesting look at how these technologies may improve outcomes for women over 50: buff.ly/EenMD1L
#AIinHealthcare #ArteraAI #PrecisionMedicine
1
83
We're excited to be featured as one of the key trends to watch at #ASCO2026! AI is making a splash in precision oncology, from drug discovery to screening to risk stratification.
mmm-online.com/news/asco-202…
2
57
We’re looking forward to connecting with clinicians and partners and continuing conversations around AI-powered precision cancer care at these events next month.
If you’ll be attending, reach out to us to set up a meeting: buff.ly/sSvk447
#ArteraOnTheGo
2
57
For low- and favorable intermediate-risk #prostatecancer patients, Artera’s #ActiveSurveillance Insights help guide active surveillance decisions with:
✓ No tissue consumption
✓ Easy to interpret results
✓ 1–2 day turnaround
#PrecisionOncology #ArteraAI
2
48
What is AI actually “seeing” in digital pathology?
Dr. Amol Shetty explores the biological pathways underlying AI-based biomarkers in #prostatecancer and how AI-detected patterns may align with known disease biology.
Learn more: buff.ly/9NJyIaf
#ArteraAI
136
#ASCO26 is almost here, and we’re proud to be sharing multiple Artera presentations across both breast and prostate cancer.
Excited to continue conversations around multimodal AI and personalized #oncology care in Chicago.
#BreastCancer #ProstateCancer #ArteraAI #ArteraOnTheGo
2
167
That's a wrap on #AUA26
Grateful for the conversations, connections, and continued momentum around AI-powered precision care in #urology. Thanks to everyone who connected with the Artera team.
#ProstateCancer #ArteraOnTheGo
1
112
ArteraAI retweeted
May 19
We're exhibiting at BAUS 2026 in London with our partners @ArteraAI
Together we're bringing the first AI multimodal risk stratification tool for localised prostate cancer to the UK, predicting 10-year metastasis risk using standard biopsy slides, with results in hours.
The only tool of its kind recommended by NCCN in the USA. Now available here.
See you there!
#BAUS2026 #ProstateCancer #Diagnexia #AIinOncology
1
1
128
How can we better stratify risk in localized prostate cancer?
CHHiP trial analysis highlighted by Anna Wilkins points to the role of multimodal AI in delivering more precise, biology-driven insights.
Learn more: buff.ly/KhY4Gxd
#ProstateCancer #AIinHealthcare
2
61
Great conversations at the Executive War College event last month.
Thank you to everyone who joined Amanda Lowe and Jennifer Archer to discuss integrating AI into pathology and the evolving regulatory and reimbursement landscape.
#DigitalPathology #AIinHealthcare #ArteraAI
1
91
Clarity matters in clinical decision-making.
Grateful to hear how the #ArteraAI Prostate Test is supporting real-world practice.
#ProstateCancer #AIinHealthcare
65
We’re heading to the APG Spring Conference in San Diego this month.
Looking forward to connecting with healthcare leaders on value-based care, population health, and the role of AI in oncology.
#APG2026 #ValueBasedCare #ArteraOnTheGo
73